US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Manufacturing, Packaging & Detailing: reports

RSS Feeds

Manufacturing, Packaging & Detailing market research reports and industry analysis

3  4  5  6    8    10  11  12  
Brand Name Pharmaceutical Manufacturing - Industry Market Research Report - in the US
5/7/2014 | published by: IBISWorld
... drugs will be important in offsetting the effects of widespread patent expirations, though a major increase in taxes and discounts to fill the Medicare coverage gap threatens profit in the industry. Pharmaceutical manufacturers develop prescription ...  |  read more...
USD 1,020
Generic Pharmaceutical Manufacturing - Industry Market Research Report - in the US
4/8/2014 | published by: IBISWorld
... healthcare reform will benefit the industry, with more consumers gaining insurance coverage for prescription drugs, improved generic drug approval processes and an established pathway to approval for biosimilars. As in the past five years, manufacturers ...  |  read more...
USD 1,020
The 11th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production
4/1/2014 | published by: BioPlan Associates, Inc.
... pages of data-rich analysis will help improve your decision-making in biomanufacturing operations, with in-depth analysis of capacity, production trends, benchmarks, and much more: Biosimilars pipeline in development In-depth analysis of key data, capacity, production trends, ...  |  read more...
USD 895
Beta Blockers (Migraine) - Forecast and Market Analysis to 2023
3/31/2014 | published by: GlobalData
... the next few years, with the exception of Botox for chronic migraine, which is expected to maintain its leading position in terms of sales. However, reformulations of mature products as well as new classes of ...  |  read more...
USD 3,495
Anti-Epileptics (Migraine) - Forecast and Market Analysis to 2023
3/31/2014 | published by: GlobalData
... next few years, with the exception of Botox for chronic migraine, which is expected to maintain its leading position in terms of sales. However, reformulations of mature products as well as new classes of therapies ...  |  read more...
USD 3,495
Lasmiditan (Migraine) - Forecast and Market Analysis to 2023
3/31/2014 | published by: GlobalData
... next few years, with the exception of Botox for chronic migraine, which is expected to maintain its leading position in terms of sales. However, reformulations of mature products as well as new classes of therapies ...  |  read more...
USD 3,495
MK-1602 (Migraine) - Forecast and Market Analysis to 2023
3/31/2014 | published by: GlobalData
... next few years, with the exception of Botox for chronic migraine, which is expected to maintain its leading position in terms of sales. However, reformulations of mature products as well as new classes of therapies ...  |  read more...
USD 3,495
Triptans (Migraine) - Forecast and Market Analysis to 2023
3/31/2014 | published by: GlobalData
... next few years, with the exception of Botox for chronic migraine, which is expected to maintain its leading position in terms of sales. However, reformulations of mature products as well as new classes of therapies ...  |  read more...
USD 3,495
Pharmaceuticals: Scandinavia Industry Guide
5/8/2014 | published by: MarketLine
... companies including key financial metrics and analysis of competitive pressures within the market. Features and benefits Save time carrying out entry-level research by identifying the size, growth, and leading players in the Scandinavian pharmaceuticals market. ...  |  read more...
USD 795
Pharmaceuticals: North America (NAFTA) Industry Guide
5/9/2014 | published by: MarketLine
... the leading companies including key financial metrics and analysis of competitive pressures within the market. Features and benefits Save time carrying out entry-level research by identifying the size, growth, and leading players in the NAFTA ...  |  read more...
USD 795
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Indonesia
4/7/2014 | published by: GlobalData
... on and analysis of the healthcare, regulatory and reimbursement landscape in Indonesia, identifying key trends in the healthcare market and providing insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure. Most importantly, the report ...  |  read more...
USD 1,995
Pharmaceuticals in Turkey: ISIC 2423
3/28/2014 | published by: Euromonitor International
... at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing ...  |  read more...
USD 600
Pakistan Pharmaceuticals and Healthcare Report Q3 2014
5/7/2014 | published by: Business Monitor International
... forpharmaceutical research and development, and an ineffective regulatory regime, will continue to determultinational firms over the long term. We note that, with the non-communicable disease burden -particularly that of diabetes - set to rise, considerable ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare : Ukraine Pharmaceuticals and Healthcare Report Q3 2014
6/4/2014 | published by: Business Monitor International
... region. In 2014, owing to the distressed economicsituation in the country, drugmakers can expect a challenging business environment and capital outflowrestrictions. Import taxes, pricing restrictions, and exchange rate volatility present significant risks todrugmakers operating in ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report - Belarus Q3 2014
6/11/2014 | published by: Business Monitor International
... escalating trade war with Russia. If Russo-Belarusian relations cannot be patched up, state revenues are set to decline considerably, the net exports deficit will widen significantly and real GDP growth will decline. There are downside ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report - Botswana Q3 2014
6/11/2014 | published by: Business Monitor International
... healthcare aims remain a risk, as issues such as counterfeit pharmaceuticalsand expired products highlights issues in drug procurement, thereby limiting healthcare access. While Botswana offers a relatively stable environment for pharmaceutical and healthcare investors, low ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report - China Q3 2014
6/11/2014 | published by: Business Monitor International
... economic slowdown. Given the attractiveness of the Chinese pharmaceutical market (due to its ageing population, increasingly personal wealth and government support for healthcare), we expect continued investments from foreign investors into the pharmaceutical and healthcare ...  |  read more...
USD 1,295
Pharmaceuticals: Calming and Sleeping in France
6/5/2014 | published by: Euromonitor International
... rates in 2012 and 2013: Energy/tonicity and anti-stress/”light” sedatives. The success of their apparently opposite positioning could be surprising at first sight, nonetheless is logical according to a manufacturer. When the balance of energy and ...  |  read more...
USD 900
KSA Healthcare Market: Complete Perspective 2014
5/19/2014 | published by: Oryx Business Intelligence Ltd.
... diagrams to explain complex structures and processes, creating an easy understanding of concepts and systems pertaining to the healthcare sector regulations, business processes, information technology and other systems. Separated into three parts, the first part ...  |  read more...
USD 1,735
Pharmaceutical Preparations Manufacturing in the UK - Industry Market Research Report
3/19/2014 | published by: IBISWorld
... wadding, gauze, bandages and dressings, and that prepare botanical products for pharmaceutical use. This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are ...  |  read more...
USD 920
Pharmaceuticals: BRIC (Brazil, Russia, India, China) Industry Guide
5/9/2014 | published by: MarketLine
... descriptions of the leading companies including key financial metrics and analysis of competitive pressures within the market. Features and benefits Save time carrying out entry-level research by identifying the size, growth, and leading players in ...  |  read more...
USD 995
Antibiotics: Technologies and Global Markets
5/1/2014 | published by: BCC Research
... This report provides: An overview of the global market for systemic antibiotics. Analyses of global market trends, with data from 2013, and projections of compound annual growth rates (CAGRs) through 2018. Details on the factors ...  |  read more...
USD 6,650
Denmark Pharmaceuticals and Healthcare Report Q2 2014
4/16/2014 | published by: Business Monitor International
... population. This demand could provide opportunities for private healthcare providers to expand asthe government continues its restructuring and cost containment measures across the public healthcaresector. Headline Expenditure Projections Pharmaceuticals: DKK20.20bn (US$3.58bn) in 2013 to DKK20.02bn ...  |  read more...
USD 1,295
Cardiovascular Drugs Markets in China
5/22/2014 | published by: Asia Market Information & Development Company
... new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2003, 2008 and 2013) and long-term forecasts through 2018 and ...  |  read more...
USD 4,000
Austria Pharmaceuticals and Healthcare Report Q3 2014
5/28/2014 | published by: Business Monitor International
... period. We have revised the healthcare andpharmaceutical market forecast slightly upwards to reflect this. The EUR-USD exchange rate continues toprovide investment opportunities for overseas investors. In the medium term, Austria's pharmaceutical andhealthcare spending will post ...  |  read more...
USD 1,295
3  4  5  6    8    10  11  12